UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004004
Receipt number R000004384
Scientific Title The developmental mechanisms of gastric cancer and esophageal adenocarcinoma
Date of disclosure of the study information 2010/08/06
Last modified on 2017/11/17 20:00:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The developmental mechanisms of gastric cancer and esophageal adenocarcinoma

Acronym

The developmental mechanisms of gastric cancer and esophageal adenocarcinoma

Scientific Title

The developmental mechanisms of gastric cancer and esophageal adenocarcinoma

Scientific Title:Acronym

The developmental mechanisms of gastric cancer and esophageal adenocarcinoma

Region

Japan North America


Condition

Condition

gastric cancer,esophageal adenocarcinoma
Barrett's esophageal epithelium

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To identify the genes causing elongation of Barrett's esophageal epithelium and subsequent development of gastric cancer after endoscopic resection and H. pylori eradication

Basic objectives2

Others

Basic objectives -Others

To identify the risk markers related with elongation of Barrett's esophageal epithelium and subsequent development of gastric cancer after endoscopic resection and H. pylori eradication

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Genes expressions including the micro RNA in the patients with Barrett's esophageal epithelium or gastric cancer after endoscopic resection before and after H. pylori eradication

Key secondary outcomes

comparison of gene expression in the Barrett epithelium between American and Japanese


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Gene

Interventions/Control_1

H. pylori eradication
triple therapy 1 week

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients with Barrett's esophageal epithelium and the patietns with endoscopic resection for early gastric cacner and H. pylori eradication

Key exclusion criteria

taking NSAIDs
history of gastrectomy or eradication
haemorrhagic diseases
insulin dependent diabetes mellitus cirrhosis
renal failure

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akiko shiotani

Organization

Kawasaki Medical School

Division name

Gastroenterology

Zip code


Address

577,Matsushima,Kurashiki,Okayama

TEL

81864624444

Email

shiotani@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akiko shiotani

Organization

Kawasaki Medical School

Division name

Gastroenterology

Zip code


Address

577,Matsushima,Kurashiki,Okayama

TEL

81-86-462-1111

Homepage URL


Email

shiotani@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for Scientific Research (C)

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 08 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2017 Year 10 Month 31 Day


Other

Other related information



Management information

Registered date

2010 Year 08 Month 06 Day

Last modified on

2017 Year 11 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004384


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name